Reality of Rare Diseases: A Unique Perspective About Rare Diseases
Top 10 Most Promising Drugs In The Amyotrophic Lateral Sclerosis Treatment Landscape
recent-pharma-news-updates-for-adarx-ixaka-novocure-vor-biopharma
ADARx Raises $75M Series B; Fast Trac...

ADARx bags USD 75 Million to advance its RNA tech pipeline ADARx Pharmaceuticals, a biotechnology company d...

phenylketonuria-market
Which Pipeline Therapy is Expected to...

Phenylketonuria is an inherited disorder characterized by the absence or deficiency of an enzyme called phe...

pharma-happenings-for-roche-allstripes-datavant-bluewillow-shape-therapeutics
Shape Therapeutics-Roche’s Deal...

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 Billion Seattle biotech firm Shape T...

pharma-happenings-for-merck-abbvie-incyte-aprea-eisai
Merck’s Keytruda Approval; Abbvie’s Venetoclax; Aprea’s Eprenetapopt; CRL to Incyte’s Retif...

FDA Approves Keytruda in Both Adjuvant and Neoadjuvant Setting in High-Risk Early-Stage TNBCIn July 2021, the US FDA approved pembrolizumab (Keytruda) for high-risk, early-stage triple-negativ...


primary-hyperoxaluria-market-cagr-size-share-trends-growth-and-key-companies
Primary Hyperoxaluria Market Size Observes Growth with a Substantial CAGR

Primary hyperoxaluria (PH) is a rare autosomal genetic form of Hyperoxaluria, a condition that leads to the excessive urinary excretion of oxalate. Till now, three distinct hereditary enzymatic de...


Angelman syndrome
Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current moment because of a shortage of any approved therapy option available in the market.The Angelman Syndrome c...


adult-onset-stills-disease-treatment-market
Essential Demands Impinge the Evolving Adult-onset Still’s Disease Treatment Market

Adult-onset Still’s Disease (AoSD), alternatively known as systemic-onset juvenile idiopathic arthritis, is a rare systemic inflammatory disorder of unknown etiology. There are three main patterns...


recent-pharma-biotech-news-updates-for-sanofi-gsk-apellis-innocare-landos
InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio...

InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in ChinaInnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today...


Alagille Syndrome Market
Rising Awareness, Key Companies, Emerging Therapies? What is Shaping the Alagille Syndrome Market

Alagille syndrome (ALGS), also referred to as Alagille–Watson syndrome, is a rare autosomal dominant condition. Mutation in JAG1 or NOTCH2 gene causes the condition to occur, but most of the indiv...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...